Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis

被引：1
|
作者：
Suhling, Hendrik [1 ]
Hinze, Christopher Alexander [1 ]
Welte, Tobias [1 ]
Werfel, Thomas [2 ]
Traidl, Stephan [2 ]
机构：
[1] Hannover Med Sch, Dept Resp Med & Infect Dis, Hannover, Germany
[2] Hannover Med Sch, Dept Dermatol & Allergy, Hannover, Germany
来源：
RESPIRATION | 2023年 / 102卷 / 12期
关键词：
Severe asthma; Dupilumab; Tezepelumab; Side effects;
D O I：
10.1159/000534924
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Introduction: This is the first report of a patient with severe asthma and atopic dermatitis that developed local perioral skin infection which onset coincided with the patient's treatment with dupilumab (candida albicans) and later with tezepelumab (microscopic detection of yeast). Case Presentation: Besides moderate headache, macular exanthema was found after administration of tezepelumab, which was subsequently accompanied by a worsening of symptoms upon reexposure to the treatment. Both sensations needed multidisciplinary treatment and both antibody therapies were stopped.
引用
收藏
页码：1016 / 1019
页数：4
相关论文
共 50 条
  • [1] Use of dupilumab in a patient with atopic dermatitis, severe asthma, andHIVinfection
    Brodska, Petra
    Panzner, Petr
    Sedlacek, Dalibor
    Terl, Milan
    Cetkovska, Petra
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [2] Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis
    Gkalpakiotis, S.
    Arenberger, P.
    Skalicka, P.
    Arenbergerova, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (06) : E281 - E283
  • [3] Success of dupilumab as a monotherapy in an adult patient affected by severe uncontrolled asthma and atopic dermatitis
    Tolino, Ersilia
    Proietti, Ilaria
    Sarni, Antonella
    Bernardini, Nicoletta
    Mambrin, Alessandra
    Balduzzi, Veronica
    Maddalena, Patrizia
    Marchesiello, Anna
    Michelini, Simone
    Volpe, Salvatore
    Skroza, Nevena
    Potenza, Concetta
    DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [4] Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
    Dubini, Marco
    Benzecry, Valentina
    Rivolta, Federica
    Sangalli, Andrea
    Marzano, Angelo Valerio
    Pravettoni, Valerio
    Tavecchio, Simona
    Ferrucci, Silvia Mariel
    FRONTIERS IN ALLERGY, 2023, 4
  • [5] The use of selective Th2 blocker dupilumab for the treatment of atopic dermatitis in a heart transplant patient: Case report
    Sklover, Lindsay
    Nielson, Colton
    De Benedetto, Anna
    DERMATOLOGIC THERAPY, 2019, 32 (06)
  • [6] Dupilumab in Children and Adolescents with Severe Atopic Dermatitis and Severe Asthma: A Case Series
    Russo, Daniele
    Pellegrino, Giulia Michela
    Di Filippo, Paola
    Ruggiero, Teresa
    Di Pillo, Sabrina
    Chiarelli, Francesco
    Papa, Giuseppe Francesco Sferrazza
    Attanasi, Marina
    APPLIED SCIENCES-BASEL, 2023, 13 (19):
  • [7] Dupilumab for the Treatment of Severe Atopic Dermatitis in an Immunosuppressed Transplant Patient
    Ghafari-Saravi, Afsoon
    Greiling, Teri M.
    DERMATITIS, 2024, 35 : S109 - S110
  • [8] Dupilumab reduces the Frequency of Infection in a Patient with severe atopic Dermatitis
    Kohlmann, J.
    Simon, J-C
    Treudler, R.
    Ziemer, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 146 - 147
  • [9] Management of inadequate response and adverse effects to dupilumab in atopic dermatitis
    Narla, Shanthi
    Silverberg, Jonathan, I
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (03) : 628 - 636
  • [10] Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?
    Carlo Mümmler
    Bernd Kemmerich
    Jürgen Behr
    Nikolaus Kneidinger
    Katrin Milger
    Allergy, Asthma & Clinical Immunology, 16
12345